Scarica l'app Stockscreener
43.73
0.27%
-0.12
Pre-mercato:
43.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Artivion Inc Borsa (AORT) Ultime notizie
Artivion stock hits 52-week high at 43.93 USD By Investing.com - Investing.com Australia
Artivion at Canaccord Conference: Strategic Growth and Innovation - Investing.com
Artivion's (AORT) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Can Artivion Inc. ride the EV wavePositive Outlook Long-Term Picks - kangso.co.kr
Revenues Tell The Story For Artivion, Inc. (NYSE:AORT) As Its Stock Soars 37% - simplywall.st
Artivion, Inc. (NYSE:AORT) Q2 2025 Earnings Call Transcript - Insider Monkey
Artivion Inc. Reports Strong Q2 Earnings and Positive Outlook - TipRanks
Artivion Appoints Lance Berry as COO, Raises Earnings Guidance - AInvest
Artivion Appoints Lance Berry as COO - MarketScreener
Artivion Appoints Lance A. Berry as COO - TipRanks
Artivion Reaches Analyst Target Price - Nasdaq
Artivion Shows Market Leadership With Jump To 93 RS Rating - Investor's Business Daily
Artivion Surges on Improved 2025 Financial Outlook - StocksToTrade
Artivion’s Stocks Surge as Q2 Financials Exceed Expectations - timothysykes.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Artivion (NYSE:AORT) Stock - Defense World
What technical models suggest about Artivion Inc.’s comebackPredictive Short-Term Market Reversal Alerts - Newser
Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth - MSN
Artivion's Q2 Earnings Surge: A High-Margin Medical Innovation Play with Undervalued Potential - AInvest
Artivion, Inc.'s (NYSE:AORT) 26% Jump Shows Its Popularity With Investors - 富途牛牛
Artivion price target raised to $45 from $32 at Needham - Yahoo Finance
Artivion Second Quarter 2025 Earnings: Beats Expectations - uk.finance.yahoo.com
Artivion Elevates 2025 Revenue Projection Amid Strong Q2 Earnings - StocksToTrade
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $40 to $45 - 富途牛牛
Artivion 2025 Q2 Earnings Strong Performance with Net Income Surges 163% - AInvest
Artivion price target raised to $41 from $35 at Canaccord - MSN
Zurcher Kantonalbank Zurich Cantonalbank Raises Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) Shares Gap Up on Better-Than-Expected Earnings - Defense World
Is Artivion Inc. stock heavily shortedBest ROI Stock Strategies - thegnnews.com
Artivion (NYSE:AORT) Stock Rating Upgraded by Wall Street Zen - Defense World
Comparing Artivion Inc. in custom built stock radarsSector-Wise Equity Performance Trend Forecast - Newser
Artivion Inc. stock trend forecastFree Swing Trading Entry Point Signals - Newser
Artivion (AORT): Canaccord Genuity Raises Price Target to $41.00 - GuruFocus
Artivion: Canaccord Genuity Raises PT to $41 from $35, Maintains Buy Rating - AInvest
Artivion’s Surging Stock: Rising Star or Temporary Miracle? - timothysykes.com
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $35 to $45 - 富途牛牛
Artivion (AORT): Accelerating Growth and Margin Expansion in a High-Margin Medical Device Niche - AInvest
Artivion Raises 2025 Revenue Guidance to $435M-$443M, Driven by On-X and Stent Grafts. - AInvest
Why Is Artivion (AORT) Stock Rocketing Higher Today - Yahoo Finance
Artivion: JMP Securities Raises PT to $42 from $33, Maintains Market Outperform - AInvest
ARTIVION, INC. SEC 10-Q Report - TradingView
Artivion stock price target raised by Stifel to $40 on strong AMDS launch - Investing.com Nigeria
Stifel Raises Artivion's PT to $40, Maintains Buy Rating - AInvest
Needham raises Artivion stock price target to $45 on growth acceleration - Investing.com Australia
Artivion Exceeds Q2 Revenue Estimates, Stock Jumps 13.1% - AInvest
Artivion: Needham Keeps Buy Rating, Raises PT to $45 from $32 - AInvest
High Insider Ownership and Revenue Growth: Top US Growth Companies - AInvest
Artivion stock price target raised to $41 from $35 at Canaccord on strong Q2 - Investing.com UK
Artivion price target raised to $42 from $33 at Citizens JMP - TipRanks
Oppenheimer raises Artivion stock price target to $40 on strong Q2 results - Investing.com Canada
Artivion revenue up 15% to USD 113M in Q2 2025 - Medical Buyer
Oppenheimer lowers Artivion stock price target to $40 from $42, maintains Outperform By Investing.com - Investing.com South Africa
Artivion's (NYSE:AORT) growing losses don't faze investors as the stock lifts 5.8% this past week - simplywall.st
Earnings call transcript: Artivion Q2 2025 reports strong revenue growth By Investing.com - Investing.com Canada
Earnings call transcript: Artivion Q2 2025 reports strong revenue growth - Investing.com
Artivion Q2 2025 slides: Revenue jumps 14%, guidance raised on strong product growth - Investing.com Nigeria
Artivion stock price target raised to $42 from $33 at JMP on strong growth - Investing.com Nigeria
Artivion (NYSE:AORT) Reports Strong Q2, Stock Jumps 13.1% - Yahoo Finance
Artivion’s Revenue And Profits Beat Expectations With Debt Cutback - Finimize
Artivion: Q2 Earnings Snapshot - Connecticut Post
Artivion Inc (AORT) Q2 2025 Earnings Call Highlights: Strong Rev - GuruFocus
0.31%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):